Complex Generic Portfolio

About Saptalis Pharmaceuticals

Saptalis Pharmaceuticals is a private, commercial-stage generics and specialty pharma company headquartered in Great Neck, New York. Leveraging expertise in complex formulations and drug delivery, the company builds a portfolio of generic and branded products targeting therapeutic areas with high demand and limited competition. Its strategy involves developing difficult-to-manufacture generics and niche specialty products to capture market share and drive revenue growth in a cost-conscious healthcare environment.

About Strides Pharma

Strides Pharma Science Limited is a multinational pharmaceutical company with a mission to make quality healthcare accessible globally through a hybrid business model spanning regulated and emerging markets. Founded in 1990, it has evolved from a domestic Indian manufacturer into a global leader in complex generics and specialty pharmaceuticals, leveraging a vertically integrated structure with advanced manufacturing and R&D. Key achievements include a 5x increase in Q4 FY2025 net profit, a strategic 'In Africa, For Africa' initiative, and a robust portfolio of USFDA-approved facilities, positioning it for sustainable growth in the global generics market.

About Bora Pharmaceuticals

Bora Pharmaceuticals has established itself as a premier hybrid CDMO and pharmaceutical developer in Asia, achieving significant scale with a market capitalization exceeding $57 billion. The company's strategy successfully integrates high-margin contract services with proprietary drug development, creating a diversified and resilient revenue model. Its core achievements include building PIC/S and FDA-compliant manufacturing facilities, developing a robust pipeline of complex generics and specialty products, and securing a strong position as a critical supply chain partner for multinational pharmaceutical companies.

Therapeutic Areas